JAGX: SEC Form 424B5 filed by Jaguar Health Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for JAGX
Across the 30 sessions after earlier JAGX headlines, the stock closed higher 12 times and lower 18 times, with a median move of 4.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | JAGX | SPY |
|---|---|---|---|
| Aug 26, 2026 | Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs | -0.6% | +0.0% |
| Aug 20, 2026 | Jaguar Health Reports Second Quarter 2026 Financials | -5.5% | -0.8% |
| Aug 18, 2026 | Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates | +11.2% | -0.7% |
| Aug 5, 2026 | Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1 | +5.5% | -0.2% |
| Jul 28, 2026 | Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog | -3.5% | +0.2% |
| Jul 22, 2026 | Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID) | +5.6% | -0.1% |
Quantisnow market dataNASDAQ
JAGX
Jaguar Health Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2015
Get push alerts for JAGX
Full JAGX profile on Quantisnow Follow JAGX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time